Ethyl Acetate

Ethyl Acetate

SCHEMBL3986904

CC(C)C(C)(N)C(C)C.CCOC(C)=O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.58
LMNA P02545 1/20 0.58
HSD17B10 Q99714 1/20 0.58
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MMP8 P22894 1/20 0.37
GAA P10253 3/20 0.34
MGAM O43451 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
SOAT1 P35610 1/20 0.34
HPGD P15428 3/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
METAP2 P50579 1/20 0.33
METAP1 P53582 1/20 0.33
CPB2 Q96IY4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL11160380 0.84 ALDH1A1 (0.74) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL28010273 0.80 ALDH1A1 (0.54) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL6217833 0.80 ALDH1A1 (0.74) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL4899372 0.79 ALDH1A1 (0.58) ALDH1A1LMNAHSD17B10ALOX15TSHR
SCHEMBL436746 0.78 ALDH1A1 (0.50) ALDH1A1HSD17B10TSHRGAA
Ethyl Acetate SCHEMBL5410446 0.78 ALDH1A1 (0.70) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL18725338 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL1428083 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL6544500 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR
Ethyl Acetate SCHEMBL3227893 0.77 ALDH1A1 (0.78) ALDH1A1LMNAHSD17B10ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2064191-A1 ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2009-06-03 EP disclosed
EP-2061771-A1 ASPARTYL PROTEASE INHIBITORS CONTAINING A TRICYCLIC RING SYSTEM SCHERING CORPORATION (US) 2009-05-27 EP disclosed
EP-2032542-A2 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2009-03-11 EP disclosed
WO-2008073370-A1 ASPARTYL PROTEASE INHIBITORS CONTAINING A TRICYCLIC RING SYSTEM SCHERING CORPORATION (US) 2008-06-19 WO disclosed
WO-2008073365-A1 ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2008-06-19 WO disclosed
EP-1902057-A1 MACROCYCLIC HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2008-03-26 EP disclosed
EP-1896478-A2 ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2008-03-12 EP disclosed
WO-2007146225-A2 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2007-12-21 WO disclosed
WO-2006138195-A1 MACROCYCLIC HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2006-12-28 WO disclosed
WO-2006138264-A2 ASPARTYL PROTEASE INHIBITORS SCHERING CORPORATION (US) 2006-12-28 WO disclosed
CN-1471537-A Synthons for oligonucleotide synthesis ƽ 2004-01-28 CN disclosed
CN-1032061-C Amino alkyl pyrrolidyl carbapenem derivative UNIVERSAL PHARMACEUTICAL CO LT (JP) 1996-06-19 CN disclosed
CN-1073176-A Amino alkyl pyrrolidyl carbapenem derivative UNIVERSAL PHARMACEUTICAL CO LT (JP) 1993-06-16 CN disclosed